Strong Industry Focus ChRi Laboratories specializes in pharmaceutical-grade cannabis testing, leveraging ISO 17025 accreditation and FDA/DEA experience, which positions them as a trusted partner for businesses seeking reliable and compliant lab services in Minnesota's rapidly growing cannabis market.

Market Expansion Having established itself in Minnesota's medical and adult-use cannabis markets since 2012, ChRi Labs remains focused on elevating industry standards, offering opportunities to collaborate with cannabis operators looking for fast, clear, and trustworthy testing solutions.

Advanced Technology Stack Utilizing a modern tech stack, including JSON-LD and other industry-standard tools, ChRi Labs demonstrates a commitment to technical excellence, which can appeal to innovative cannabis companies seeking cutting-edge testing capabilities.

Financial Resources With revenues estimated between 100 million to 250 million dollars, ChRi Labs has solid financial backing that supports expanding service offerings and building long-term partnerships with clients seeking dependable testing providers.

Industry Networking Participation in public events like the St. Paul conference enhances visibility and credibility among industry stakeholders, creating opportunities for sales teams to connect with influential regulators, growers, and manufacturers looking for quality assurance services.